Healthcare
7,000 steps a day may be the new magic number for better health: Lancet Study
A recent study in The Lancet Public Health reveals that walking at least 7,000 steps daily significantly reduces the risk of cardiovascular disease, cancer, type-2 diabetes, dementia, depression, and falls. Even 4,000 steps show health benefits compared to minimal activity. Researchers suggest 7,000 steps is a more achievable goal than 10,000 for improved health.
Delhi HC seeks Dr Reddy's reply in Novo patent dispute
The Delhi High Court has directed Dr. Reddy's Labs to respond to Novo Nordisk's injunction petition concerning its weight-loss drug, semaglutide (Wegovy). Novo Nordisk alleges patent infringement, prompting the court's action. An IP expert suggests Dr. Reddy's Labs may need to justify its semaglutide exports, as Novo Nordisk's patent is set to expire in March of next year.
Apollo, Siemens collaborate to advance innovation in liver healthcare
Apollo Hospitals and Siemens Healthineers are collaborating to innovate liver healthcare through research. The partnership focuses on quantitative ultrasound imaging and AI-driven solutions to improve liver disease management. Their joint effort aims to enhance early detection, risk stratification, and monitoring of treatment response, ultimately improving patient outcomes and quality of life.
Obesity lab: India becomes ground zero for weight-loss drug race
India is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the impending patent expirations of blockbuster drugs. Pharmaceutical giants are launching innovative anti-obesity medications, while Indian companies gear up to produce affordable generic versions. Government support and incentives further position India as a major exporter of these crucial medications.
Mind your posture: Doctors cite long hours in front of screen for increasing lifestyle diseases
Young professionals are increasingly facing lifestyle ailments due to prolonged sitting and screen time, leading to a 30-40% rise in muscular, spinal, eye, heart, and mental health disorders. The pressure to stay relevant in an AI-driven workplace exacerbates these issues, causing conditions like Tech Neck and Digital Fatigue Syndrome.
New dilemma looms for India’s private hospitals: More beds, but few can lie in them
India's private hospital sector faces a potential overcapacity in major cities due to significant upcoming bed additions, even as smaller towns lack sufficient beds. While demand for quality healthcare grows, driven by rising incomes and insurance coverage, analysts caution that this expansion could strain profitability.
Central drugs laboratories find 55 samples to be 'not of standard quality' in June
In June 2025, central drugs laboratories discovered 55 drug samples failing quality standards, while state labs found 130 similarly substandard. The CDSCO regularly posts lists of these and spurious drugs. Additionally, one drug sample each from Bihar and Delhi, and two from Telangana, were identified as spurious, prompting investigations and regulatory action.
Kenvue ties up with API to launch India's first Cough Clinics
Kenvue, makers of Benadryl, introduces 'Cough Clinics' in partnership with the Association of Physicians of India. This initiative aims to establish ten Centers of Excellence across India. These clinics will enhance healthcare professionals' knowledge of cough evaluation. The goal is to promote science-backed approaches to treatment. The clinics will offer specialized training and tools for physicians.
Domestic med-tech companies flag security threat from Chinese devices
Indian medical tech leaders have voiced concerns to the government regarding the security risks associated with importing Chinese healthcare devices. They highlighted potential misuse for surveillance, cyberattacks, and data breaches, urging stricter scrutiny and measures to prevent rerouting via other countries. Manufacturers also seek streamlined regulations and policy support to boost domestic production and achieve self-reliance.
Cupid invests in GII Healthcare Investment; enters Gulf region
Cupid Ltd has strategically invested in GII Healthcare Investment Ltd, managed by Gulf Islamic Investments, marking its entry into the Gulf region. While financial details remain undisclosed, this move secures a dollar-denominated asset for Cupid. The investment aligns with the company's personal care products and opens doors for distribution synergies within the GCC patient demographic.
RECENT NEWS
- Shah Rukh Khan Vs Salman Khan: One King, the other Sultan, both superstars, know who is more rich between Salman and Shah Rukh
- 'Reason he can't stand up to Trump is ...': Rahul's fresh charge at PM; claims 'Modi's hands are tied'
- Parliament logjam over SIR: Congress says discussion on 'votebandi' non-negotiable; asks why ignore Dhankar's 2023 ruling?
- Why is India buying so much war equipment worth Rs 67,000 crore? Missiles, aircraft, drones, and more
- 'Will call PM Modi': Brazil's Lula snubs Trump amid tariff row; rejects offer to reach out
